NEW YORK, Aug. 24, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Curaleaf Holdings, Inc. ("Curaleaf" or the "Company") (OTCMKTS: CURLF) and certain of its officers.  The class action, filed in United States District Court, for the Eastern District of New

FORT LAUDERDALE, Fla., Aug. 23, 2019 /PRNewswire/ -- Recovery Unplugged is thrilled to announce that our VP of Business Development,

BUFFALO, N.Y., Aug. 23, 2019 /PRNewswire/ -- This summer, Aflac, the leader in supplemental insurance sales at U.S. worksites, is bringing My Special Aflac Ducks to Roswell Park Comprehensive Cancer

BEIJING, Aug. 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months end

AQUEBOGUE, N.Y., Aug. 23, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is correcting its 08.22.19 Announcement of a Voluntary Recall for Veterinary Ophthalmic drug products and lots, within expiry, identified below. Corrections are being made only for the Vetropolycin and Puralube products

SANTA ANA, Calif., Aug. 23, 2019 /PRNewswire/ -- Care To Stay Home® has been ranked the #1

SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ -- Zanthion™ launches SMART Lifetime, a complete personal and home security system for life, with no subscription fees and proactive health monitoring with crowdsourced awareness. Zanthion is an AI digital healthcare company with a class-leading Senior Care IoT Platform."Zanthion's sole goal is dignity of life f

CLEVELAND, Aug. 23, 2019 /PRNewswire/ -- According to Liquid Silicone Rubber, a new study from The Freedonia Group, the market for liquid silicone rubber (LSR) is on pace to increase 8.3% annually through 2023, propelled in part by an expanding range of products and applications.

INDIANAPOLIS, Aug. 23, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) announced today that baricitinib met the primary endpoint in BREEZE-AD7, the third pivotal Phase 3 trial in the BREEZE-AD program to be completed in 2019. BREEZE-AD7, an investigational study evaluating the efficacy and safety of baricitinib, an oral JAK inhibitor, to treat mo

PITTSBURGH, Aug. 23, 2019 /PRNewswire/ -- Researchers from Carnegie Mellon University (CMU) and Nanyang Technological University in Singapore have developed an organ-on-an-electronic-chip platform, which uses bioelectrical sensors to measure the electrophysiology of the heart cells i